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Abstract
Background: Most adults do not achieve the 150 minutes weekly of at least moderate intensity activity
recommended for health. Adults’ most common physical activity (PA) is walking, light intensity if strolling, moderate
if brisker. Pedometers can increase walking; however, most trials have been short-term, have combined pedometer
and support effects, and have not reported PA intensity. This trial will investigate whether pedometers, with or
without nurse support, can help less active 45–75 year olds to increase their PA over 12 months.
Methods/design: Design: Primary care-based 3-arm randomized controlled trial with 12-month follow-up and
health economic and qualitative evaluations.
Participants: Less active 45–75 year olds (n = 993) will be recruited by post from six South West London general
practices, maximum of two per household and households randomised into three groups. Step-count and time
spent at different PA intensities will be assessed for 7 days at baseline, 3 and 12 months by accelerometer.
Questionnaires and anthropometric assessments will be completed.
Intervention: The pedometer-alone group will be posted a pedometer (Yamax Digi-Walker SW-200), handbook and
diary detailing a 12-week pedometer-based walking programme, using targets from their baseline assessment. The
pedometer-plus-support group will additionally receive three practice nurse PA consultations. The handbook, diary
and consultations include behaviour change techniques (e.g., self-monitoring, goal-setting, relapse prevention
planning). The control group will receive usual care.
Outcomes: Changes in average daily step-count (primary outcome), time spent sedentary and in at least moderate
intensity PA weekly at 12 months, measured by accelerometry. Other outcomes include change in body mass index,
body fat, self-reported PA, quality of life, mood and adverse events. Cost-effectiveness will be assessed by the
incremental cost of the intervention to the National Health Service and incremental cost per change in step-count
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and per quality adjusted life year. Qualitative evaluations will explore reasons for trial non-participation and the
interventions’ acceptability.
Discussion: The PACE-UP trial will determine the effectiveness and cost-effectiveness of a pedometer-based
walking intervention delivered by post or practice nurse to less active primary care patients aged 45–75 years old.
Approaches to minimise bias and challenges anticipated in delivery will be discussed.
Trial registration: ISRCTN98538934
Keywords: Accelerometers, Behaviour change techniques, Cognitive behavioural, Middle-aged adults, Older people,
Pedometers, Physical activity, Postal, Practice nurse, Primary care, Walking intervention
Background
Benefit and risks of PA and current PA guidelines
Why is physical activity (PA) important for adults and
older adults? PA leads to reduced mortality, a reduced
risk of over 20 diseases and conditions, and improved
function, quality of life and emotional well-being [1].
Physical inactivity is the fourth leading risk factor for
global mortality [2] and a major cost burden on health
services [1].
What are the PA guidelines? Adults and older adults are
advised to be active daily and, in order to obtain health
benefits, should achieve at least 150 minutes (2 ½ hours)
per week of at least moderate intensity activity in bouts
of 10 minutes or more. One effective way to do this is
by 30 minutes of moderate intensity activity on at least
5 days weekly [1,3,4]. Regular walking is the most com-
mon PA of adults and older adults, walking at a mo-
derate pace (3 mph /5 km/h) qualifies as moderate
intensity PA [5]. Time spent being sedentary for ex-
tended periods should also be minimised, as this is an
independent disease risk factor [1] and increases steeply
from the age of 45 [6]. Whilst amongst adults in England
aged 16 and over, 39% of men and 29% of women were
judged to meet the recommended PA levels, based on
their self-reported data, only 20% and 17% of men and
women aged 60–74 met recommended levels [6], des-
pite most of these inactive older people being capable of
walking [7]. Lower socioeconomic groups [6] and Indian,
Pakistani, Bangladeshi and Chinese ethnic groups are
significantly less likely to report activity levels that meet
the recommended levels, whilst the activity levels of
other ethnic groups (Black Caribbean, Black African
and Irish) are similar to that of the general population
[8]. Surveys of adults in Europe and the USA also con-
firm that over 50% do not achieve public health PA rec-
ommendations [9,10]. Since PA, including walking, is
unreliably recalled, surveys may overestimate PA levels
[11]. Objective accelerometer measurement found that
only 5% of men and 4% of women aged 35–64 years and
5% men and 0% of women aged 65 or more achieved
the recommended PA levels, only a fraction of those
self-reporting achieving these levels [6].
What are the risks from increasing PA? Risks from a
sedentary lifestyle far exceed the risks from regular PA
[3,12,13]. Moderate intensity PA carries a low injury risk
[14], mainly musculoskeletal injury or falls [15]. Walking
is very low risk, “a near perfect exercise” [5]. Screening
participants for contraindications before participating in
light to moderate intensity PA programmes is no longer
advocated [3,16]. An important safety feature of our
study is that individualised goals can be set from the
participant’s own baseline, in line with advice that older
adults in particular should start with low intensity PA
and increase intensity gradually, the “start-low-and-go-
slow” approach [12,13].
Strategies for increasing PA
How can adults and older adults increase their PA
levels? A systematic review of PA interventions reported
moderate positive short-term effects, but findings were
limited by mainly unreliable self-report measures in moti-
vated volunteers [17]. Effective interventions explored fac-
tors associated with behavioural change, including beliefs
about costs and benefits of PA [18]. Exercise programs in
diverse populations can promote short- to medium-term
increases in PA when interventions are based on health
behaviour theoretical constructs, individually tailored with
personalised activity goals and use behavioural strategies
[3,19]. A critical review and a best practices statement on
older peoples’ PA interventions advised home rather than
gym-based programmes and behavioural strategies (e.g.,
goal-setting, self-monitoring, self-efficacy, support, relapse
prevention training) rather than health education alone
[13,20]. National Institute for Health and Clinical Excel-
lence (NICE) guidance concluded that no particular be-
haviour change model was superior and that training
should focus on generic competencies and skills rather
than specific models [21]. Starting low, but gradually
increasing to moderate intensity is promoted as best
practice, with advice to incorporate interventions into
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the daily routine (e.g., walking) [13]. A recent systematic
review concluded that walking interventions tailored
to people’s needs, targeted at the most sedentary and
delivered at the individual or household level, can be
effective, although evidence directly comparing inter-
ventions targeted at individuals, couples or households
is lacking [22].
Are pedometers helpful? Pedometers are small, inex-
pensive devices, worn at the hip, that provide direct
step-count feedback. A systematic review of 26 studies
found pedometer users increased steps/day by 2,491
(1,098–3,885) and PA levels by 27%, with significant re-
ductions in body mass index (BMI) and blood pressure
[23]. A second review (32 studies) found an average
increase of 2,000 steps/day for pedometer users [24].
Step-goals and diaries were key motivational factors
[23,24]. Several limitations were recognised. Study sizes
were relatively small and long-term effects undetermined;
many included several components (e.g., pedometer and
support) so independent effects were difficult to establish
and the inclusion of older people and men was very
limited [23,24]. Recent studies have addressed some of
these limitations. A trial of 210 older women found that
a pedometer plus behaviour change intervention in-
creased PA at 3 months but not at 6 months [25]. Two
trials in high risk groups (cardiac disease and impaired
glucose tolerance) showed sustained increases in step-
count at 12 months [26,27]. NICE recently updated its
advice from only advising pedometers as part of research
[28] to now advising their use as part of packages
including support to set realistic goals, monitoring and
feedback [29].
How do step-count goals relate to PA recommendations?
Step-count goals lead to more effective interventions, but
no specific approach to goal-setting is favoured [23]. Goals
are based on either a fixed target (e.g., 10,000 steps/day)
[30,31] or by advising incremental increases on baseline,
as a percentage (5% per week [32], 10% biweekly [33] or
20% monthly [25]) or by a fixed number of extra steps.
Those advocating a fixed number of extra daily steps have
developed step-based guidelines to fit with existing evi-
dence based guidelines with their emphasis on 30 minutes
of at least moderate intensity PA on 5 or more days weekly
[34]. Despite individual variation, moderate intensity walk-
ing appears approximately equal to at least 100 steps per
minute [34,35]. Multiplied by 30 minutes this produces a
minimum of 3,000 steps per day, to be done over and
above habitual activity. Several studies have advocated
adding in 3,000 steps/day on most days weekly, either
from the beginning [26] or by increasing incrementally
(initially an extra 1,500 steps/day and increasing) [36,37]
or increasing by 500 steps/day biweekly [27]. Studies that
advised adding 3,000 steps/day to baseline produced sig-
nificant improvements in step-counts at 3 months and
two measured outcomes at 12 months and showed
sustained improvements in step-counts [26,27], waist
circumference [26] and fasting glucose levels [27]. Al-
though there is no evidence at present to inform a
moderate intensity cadence (steps/minute) in older
adults, Tudor-Locke et al. advocate using the adult ca-
dence of 100 steps/minute in older adults (whilst
recognising that this may be unobtainable for some
individuals) and advise that the 30 minutes can be
broken down into bouts of at least 10 minutes [38].
This model was used in a primary care walking inter-
vention in 41 older people which found significant
step-count increases from baseline to week 12, main-
tained at week 24 [39,40].
Could accelerometers be useful in a pedometer-based
walking intervention? Accelerometers are small activity
monitors, worn like pedometers, more expensive, but
able to provide a time-stamped record of PA frequency
(step-counts) and intensity (activity counts). They re-
quire computer analysis and give no immediate feed-
back, functioning as blinded pedometers in objectively
measuring baseline and outcome data, but providing
objective data on time spent in different PA intensities,
including time spent in at least moderate intensity activity
and time spent sedentary, two important public health
outcomes. Pedometer studies without accelerometers have
relied on self-report measures of these outcomes. Acceler-
ometers are valid and acceptable to adults [6,41] and older
adults [6,42,43]. Although both instruments measure step-
count and are highly correlated [44,45], pedometers usu-
ally record lower step-counts, particularly at lower walking
speeds, and accelerometers cannot reliably be substituted
for pedometers at an individual level [45]. Thus, although
we will use the accelerometer to measure outcomes, we
will use a blinded pedometer, worn simultaneously at
baseline, to set individual step-count targets.
Are pedometers cost-effective? There is limited know-
ledge on the cost-effectiveness of pedometer-based in-
terventions in the UK. Recent systematic reviews that
considered the economic outcomes of pedometer-based
interventions found no evidence [46,47], partly attribut-
able to insufficient data [48]. However, a recent study
assessed the cost-effectiveness of giving an individua-
lised walking programme and pedometer with or with-
out a consultation compared with usual walking activity
alongside a trial of 79 people [49]. The incremental
cost-effectiveness ratios per person achieving an add-
itional 15,000 steps/week were £591 and £92 with and
without the consultation. However, no data on quality
of life were collected and impacts on long-term outcomes
were not estimated.
What is primary care’s role in promoting PA? Primary
care centres (general practices) in the UK provide health-
care and health promotion free at the point of access, to a
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registered list of local patients, using disease registers to
provide annual or more frequent review of chronic disor-
ders (for many of which PA will be of benefit), via a multi-
disciplinary health care team to provide continuity of care.
NICE guidance found that brief interventions in primary
care are cost-effective and therefore recommends that all
primary care practitioners should take the opportunity,
whenever possible, to identify inactive adults and provide
advice on increasing PA levels [28]. New National Health
Service health checks include adults up to age 74 and
incorporate advice on increasing PA, often by primary care
nurses [50]. Primary care nurses have been shown to be
effective at increasing PA, particularly walking, in this age
group [51]. Health professional PA advice in consultations
is individually tailored [52] and has greater impact than
other PA advice [53]. PA promotion by other routes, for
older adults in particular, is unlikely to be as effective
[54]]. Exercise prescribing guidance in primary care rein-
forces the importance of follow-up to chart progress, set
goals, solve problems, and identify and use social support
[55]; this will be an important feature of the nurse PA con-
sultations in this trial. Evaluation of the UK Step-O-Meter
Programme, delivering pedometers through primary
care, showed self-reported PA increases, but advised
investigation with a RCT design [36]. Two small trials
have assessed the effectiveness of pedometers plus PA
consultations: one showed a significant effect on step-
counts at 12 weeks in 79 middle-aged adults [37]; the
other showed a significant effect on step-counts at
12 weeks, maintained at 24 weeks in 41 older primary
care patients and called for a further, larger primary
care trial [39,40].
Theory on which the intervention is based and relevant
pilot and preparatory work. The pedometer-based inter-
vention is centred on work cited above showing that pe-
dometers can increase step-counts and PA intensity
[23,24], but extending this to ensure that the study covers
older adults, men, has a 12 month follow-up, and is de-
signed to examine pedometer and support components
separately. The patient handbook, diary and practice nurse
PA consultations will use behaviour change techniques
(BCTs) (e.g., goal-setting, self-monitoring, feedback, boost-
ing motivation, encouraging social support, addressing
barriers, relapse anticipation etc.). These techniques have
been successfully used by non-specialists in primary care
after brief training [56] and are emphasized in the Health
Trainer Handbook [57], based on evidence from a range
of psychological methods and intended for National
Health Service behaviour change programmes, with local
adaptation [57]. We have adapted the Health Trainer
Handbook for use in this trial into PACE-UP nurse and
patient handbooks, to focus specifically on PA using pe-
dometers. The BCTs have been classified according to
Michie’s refined taxonomy of BCTs for PA interventions
[58] (Tables 1 and 2). Diary recording of pedometer
step-counts provides clear material for PA goal setting,
self-monitoring and feedback, and should fit well with
this approach. Relevant pilot and preparatory work in-
cludes observational work using pedometers and accel-
erometers in primary care [42] and a trial with older
primary care patients developing the PA consultations
and pedometer-based walking intervention (PACE-Lift
trial ISRCTN42122561) [59].
Study rationale and aims
Rationale
There is a need for a large, adequately powered primary
care trial to test the effect of a pedometer-based walking
intervention, with and without nurse PA consultations
in inactive adults and older adults. It should include
follow-up to 1 year and ensure that adequate numbers
of men, older adults and individuals from diverse socio-
economic and ethnic backgrounds are included. It should
enable the effectiveness of taking part as an individual or
as a couple to be estimated. For greatest effect the inter-
vention should use step-goals and diaries and the PA con-
sultations and patient handbook should be based on
BCTs, such as those used in the Health Trainer Handbook
[57]. To objectively test the interventions’ effectiveness
on important public health outcomes, such as time
spent in at least moderate intensity activity and time
spent sedentary, accelerometer measurement of out-
comes should be included. A qualitative assessment is
needed to explore the intervention’s acceptability and
reasons for dropout and durability of effects. An eco-
nomic evaluation should be performed alongside the
trial and the costs and benefits of the alternatives,
modelled beyond the end of the trial.
Study aims
The main hypotheses to be addressed are: i) does a
3 month pedometer-based walking intervention increase
PA in inactive 45–75 year olds at 12 month follow-up; and
ii) does providing practice nurse support through PA con-
sultations provide additional benefit. The study will also
assess the cost-effectiveness of both interventions and
whether or not any effects are modified by age, gender,
body mass index or taking part as a couple, and will esti-
mate the effect of the interventions on patient reported
outcomes and anthropometric measures.
Methods/design
This paper was written according to CONSORT reporting
guidelines for RCTs of non-pharmacologic treatment [60].
Trial design
A three-arm parallel design cluster RCT with household
as the unit of randomisation comparing the following:
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a control group (usual PA); pedometer and written in-
structions by post; pedometer and support (written in-
structions and brief individually tailored PA consultations
with a practice nurse). A 1:1:1 allocation will be used. The
CONSORT flow diagram summarises the design, proce-
dures and stages (Figure 1) [60].
Practice and participant recruitment
Practice inclusion criteria
South West London general practices with a list size
>9,000; giving a commitment to participate over the
study duration; having a practice nurse to carry out the
PA consultations; and a room for the research assistant
to recruit participants and conduct assessments.
Practice recruitment
The Primary Care Research Network Greater London
will help us to identify potential participant practices
within South West London who fit the above practice
inclusion criteria. Approaches by mailed invitation, tele-
phone contact with practice managers and personal con-
tact with local general practitioners (GPs) and practice
nurses will all be used as necessary to identify practices.
We will select six from the list of potentially interested
practices to include a range of socio-demographic factors
Table 1 PACE-UP patient handbook and diary, and behavioural change techniques included
Guide to content Behavioural change
techniques [58]
Patient
handbook
Health benefits of increasing walking 1, 2
PA guidelines 4
Moderate intensity PA and relating it to number of steps
PACE-UP walking programme and step-count targets 7,9,16
Review participant baseline step-count 19
How to increase PA safely 21
Useful websites 4
How to keep going when PACE-UP programme finishes 1,2,16,26,29,35
Patient diary How to use pedometer and record steps in diary 16, 21
Frequently asked questions on PACE-UP trial
Weekly recording of step-count and walking in diary (weeks 1–12) 7,9,19,26
Achievement of targets (weeks 1–12) 10,12,13
Planning when to walk, where to walk, who to walk with 20,29
Week 2 Tips and motivators: make walking part of your daily routine 20
Week 3 Ttips and motivators: remember personal benefits, what to do if you 2,20,35
are falling behind your targets
Week 4 Keep it up: praise and reward yourself, encouraging social support 12,13,29
Week 5 Keep motivated: write down step-counts, ask for support 12,16,29
Week 6 Now we are moving: obstacles and solutions 8
Week 7 How to make these changes permanent – ideas for new walks, making time for walking, what gains
have been made so far?
38,17,11
Week 8 Maintain the gain: pacing, tips for safe exercising 9,21,35
Week 9 Be busy being active: keep monitoring with pedometer, places, people and thoughts that motivate you 16,29,36
Week 10 Change does not happen in a straight line! Preparing for setbacks 8,35
Week 11 Make it a healthy habit: building regular exercise habits, creating if-then plans 1,2,7,23
Week 12 I’ve changed: how to keep up your walking programme 16,20,29
Congratulations you have completed the programme 11,16,17
How to keep going when PACE-UP programme finishes 1,16,29
1. Provide general information on behaviour-health link; 2. Provide information on consequences to individual; 4. Provide normative information about others’
behaviour; 7. Action planning; 8. Barrier identification; 9. Set graded tasks; 10. Prompt review of behavioural goals; 11. Prompt review of outcome goals; 12. Prompt
rewards contingent on effort; 13. Prompt rewards contingent on successful behaviour; 16. Prompt self-monitoring of behaviour; 17. Prompting self-monitoring of
behavioural outcome; 19. Provide feedback on performance; 20. Provide information on when and where to perform the behaviour; 21. Provide instructions on
how to perform the behaviour; 23. Teach to use prompts/cues; 26. Prompt practice; 29. Plan social support/social change; 35. Relapse prevention/coping planning;
36. Stress management/emotional control training; 38. Time management.
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(including targeting some practices in areas with high
numbers of ethnic minority patients) and geographical cir-
cumstances based on practice postcode index of multiple
deprivation scores using national quintiles (at least 1 prac-
tice from each quintile). The index of multiple deprivation
score includes factors such as distance to services, crime
rates and road traffic accident rates, which could influence
likelihood of outdoor PA, as well as material deprivation
measures [61].
Participant inclusion criteria
Patients aged 45–75 years registered at a selected general
practice, able to walk outside the home and with no con-
traindications to increasing their moderate intensity PA
levels.
Participant exclusion criteria
In order to maximise the benefits of the intervention to
individuals and the National Health Service, the trial
Table 2 PACE-UP practice nurse physical activity consultations and behaviour change techniques included
Week Sessions Guide to session content Behavioural change
techniques [58]
1 Session 1: First steps (30 minutes)
Week 1
Review health status, current activity, health benefits of PA 1, 2
Cost-benefit analysis for increasing PA 2
PA guidelines and how to increase PA safely 4, 21
Moderate intensity PA and relating it to number of steps
Review participant baseline step-count 19,
Teach use of pedometer and recording walks and steps in diary 21, 26
Ideas for increasing steps 20
Goal-setting – PACE-UP goals or tailored to the individual patient 7, 9, 16
Use of rewards for effort and for achieving goals 12, 13
Summarise and check patient understanding, plan time for next meeting
Communication strategies to overcome resistance and promote patient-led
change
37
5 Session 2: Continuing the changes
(20 minutes) Week 5
Review step-count and walking diary 10, 19
Encourage progress in increasing walking and achieving step-count goals 12, 13
Troubleshoot any problems with pedometer or diary 8
Review target and agree goals for next stage 7, 9, 16
Barriers and facilitators to increasing PA, overcoming barriers, encouraging
support
8, 29
Pacing and avoiding boom and bust 9, 35
Check confidence levels, build confidence to make change 18, 29, 36
Summarise and check patient understanding, plan time for next meeting
Communication strategies to overcome resistance and promote patient-led
change
37
9 Session 3: Building lasting habits
(20 minutes) Week 9
Review step-count and walking diary 10, 19
Review overall progress over the sessions 11, 17
Encourage progress in increasing walking and achieving goals 12, 13
Preparing for setbacks 35
Building habits: discuss methods of maintaining lasting change, including
repetition, if-then rules and support
7, 29, 23, 29, 35
Setting goals: maintaining current activity or increasing further? 7, 9, 16, 26
Remind re contact with research assistant in 3–4 weeks
Communication strategies to overcome resistance and promote patient-led
change
37
1. Provide general information on behaviour-health link; 2. Provide information on consequences to individual; 4. Provide normative information about others’
behaviour; 7. Action planning; 8. Barrier identification; 9. Set graded tasks; 10. Prompt review of behavioural goals; 11. Prompt review of outcome goals; 12. Prompt
rewards contingent on effort; 13. Prompt rewards contingent on successful behaviour; 16. Prompt self-monitoring of behaviour; 17. Prompting self-monitoring of
behavioural outcome; 18. Prompting focus on past success; 19. Provide feedback on performance; 20. Provide information on when and where to perform the
behaviour; 21. Provide instructions on how to perform the behaviour; 23. Teach to use prompts/cues; 26. Prompt practice; 29. Plan social support/social change;
35. Relapse prevention/coping planning; 36.Stress management/emotional control training; 37. Motivational interviewing.
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Figure 1 CONSORT flow diagram for PACE-UP trial. Detailed legend: CONSORT flow diagram showing participant flow through each stage of
the randomized controlled trial (enrolment, intervention allocation, follow-up and data analysis).
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focusses on less active adults, using a single-item validated
questionnaire measure of self-reported PA as a screening
question to identify them [51]. Those individuals reporting
achieving a minimum of 150 minutes of at least moderate
intensity PA weekly [1] will be excluded. Participants
found on subsequent baseline accelerometer assessment
to be above this PA level will not be excluded, as these
patients would be included if this intervention were to
be rolled out in primary care. Other exclusions: living in
a residential or nursing home; housebound; ≥3 falls in
previous year or ≥1 fall in previous year requiring medical
attention; terminal illness; dementia or significant cogni-
tive impairment (unable to follow simple instructions);
registered blind; new onset chest pain, myocardial infarc-
tion, coronary artery bypass graft or angioplasty within the
last 3 months; medical or psychiatric condition which the
GP considers excludes the patient (e.g., acute systemic
illness such as pneumonia, unstable heart failure, unable
to move about independently, psychotic illness). Pregnant
women will also be excluded.
Participant recruitment
The number of patients aged 45–74 years will be recorded
at each practice. Practice staff will search practice elec-
tronic primary health care records to identify patients aged
45–74, using Read codes supplied by researchers and local
care home knowledge to exclude ineligible patients (as
above). Initial sampling will include 45–74 year olds, but
some individuals will become 75 before randomisation
and will still be included. A list of potentially eligible pa-
tients will be created and ordered by household, with each
household given a unique household identifier. We are
aiming to select either individuals or couples in a house-
hold, therefore we want to select a maximum of two
people per household. If a household with one individual
is selected at random, then that individual is selected. If a
household has two or more individuals then one individ-
ual is selected at random. If there is a second individual in
that household with an age difference of 15 years or less,
they will also be selected. The approach was based on pre-
vious validated work showing that this age difference is an
effective way of identifying (married or cohabiting) couples
within a household [62]. Initially, the first random sample
containing 400 eligible patients will be selected at each
practice and the list examined by practice GPs or nurses
to ensure trial suitability. Patients in these households will
then be mailed an individual trial invitation letter from the
practice and the screening question to assess activity levels
and a participant information sheet. This will make it clear
that if potential participants have any difficulties under-
standing, speaking or reading English they should bring a
family member or friend with them to the research assist-
ant appointment. The participant information sheet will
be translated into different languages if practices indicate
this to be appropriate. The 400 individuals will be con-
tacted by post in a staggered manner over 2–3 months to
avoid overwhelming the research assistants. Reminders
will be sent out to non-responders after 6–8 weeks. Fur-
ther random samples of households will be selected from
the list until required numbers have been randomised. On
the reply slip, those not wishing to participate will be
asked about reasons for declining and their willingness to
fill in a health and PA questionnaire, one of the questions
on this questionnaire will ask if they would be willing to
be interviewed about their reasons for not wanting to par-
ticipate in the trial. Patients who agree to participate in
the trial will be telephoned to arrange a baseline assess-
ment at the practice with the research assistant. Two eli-
gible people within a household will be invited together
(or apart if they prefer). Eligibility will be confirmed and
informed consent sought at this appointment.
Participant selection for the qualitative evaluation
Participant selection for the qualitative evaluation will
run parallel to the trial and will focus upon three distinct
groups. i) Trial ‘non-participants’ who agree to be inter-
viewed, to explore factors influencing their decision not
to participate. ii) Purposive samples of four groups of
trial participants, after 12-month follow-up (including
samples of those who did and did not increase their PA
in each of the two intervention arms). The samples will
reflect the range of socio-demographic characteristics of
participants including ethnicity. iii) All practice nurses
(maximum 12 if two per practice) will be invited to par-
ticipate in a focus group to find out their thoughts about
the interventions’ acceptability and use in PA consulta-
tions. Interviewing with study participants will continue
until no new themes are identified (approximately 55–80
are anticipated, 15–20 for the ‘non-participants’ and 10–15
for each of the four groups of trial participants).
Baseline assessment
The following assessments will be carried out by the
research assistant at the patient’s general practice.
i) Questionnaire measures – Socio-economic-
demographic measures: marital status, ethnic group,
occupation, employment, household composition,
home ownership. Self-reported PA: modified
Zutphen [63]. Health problems and lifestyle factors:
self-reported chronic diseases (e.g., heart disease,
lung disease, arthritis, depression), disability [64],
medication, smoking and alcohol. Patient Reported
Outcomes (PROs): exercise self-efficacy [65], anxiety
and depression (Hospital Anxiety & Depression
Scale [66]), perceived health status (EQ-5D) [67],
loneliness [68]. A further self-report questionnaire of
7-day PA recall using the General Practice PA
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Questionnaire (GPPAQ) [69] and International
Physical Activity Questionnaire (IPAQ) [70] will be
completed after wearing the PA monitors for 7 days
and posted back with them.
ii) Falls Risk Assessment Tool [71] – This will be
assessed using self-report items and by direct
observation of the ability to rise from a chair of knee
height without using their arms.
iii)Anthropometric measures – Height (measured in
bare feet to neared 0.5 cm using a stadiometer);
weight (measured to nearest 0.1 kg), body fat,
bioimpedance (using Tanita body composition
analyser BC-418 MA); and waist and hip
circumference (using standard technique and tape
measure with clear plastic slider).
iv)Objective PA assessment – Measurement of usual PA
levels, wearing an accelerometer and a blinded
pedometer (Yamax Digiwalker CW200) on a belt
over one hip, all day for 7 days, only removing for
bathing. A diary is also provided to record what
activities are done and how long for. The monitors,
belt and diary will be posted back on completion.
The Actigraph (GT3X +Manufacturing Technology
Inc., Fl. USA) measures vertical accelerations in
magnitudes from 0.05–2.0 g sampled at 30 Hz then
summed over a selected (5 s) time period, it can
record PA continuously for up to 21 days. The
output, activity counts per unit of time, distinguishes
between different walking speeds and PA intensities,
using standard cut-offs [42,43]. The pedometer
function on the accelerometer will be used for
baseline and outcome measurement of step-counts
for the trial. Participants will be offered the option
of text messaging to remind them to wear the
accelerometer each day and to return it after the
7 days. Once it is returned, the participants receive a
£10 gift voucher.
Randomisation procedure
After all participants in a household have completed the
baseline assessment and returned the accelerometer with
at least 5 complete days of ≥9 hours / 540 minutes re-
cording, the RA will allocate to the trial groups using an
internet randomisation service to ensure independence
of the allocation. Participants who do not provide the
required data, will be asked to wear the accelerometers
for another 7 days or excluded, if this is not possible. To
avoid couple contamination, randomisation will be at
household level. Block randomisation will be used within
practice with random sized blocks to ensure balance in
the groups and an even workload for nurses. The research
assistant will inform participants by telephone of their
group allocation.
Nature of the complex intervention
Twelve-week pedometer-based walking intervention deliv-
ered either by post with written instructions (pedometer
group) or delivered in the context of three practice nurse
PA consultations (pedometer plus nurse support group).
Table 3 provides details of the complex intervention com-
ponents. (Figure 2)
Procedure for control group (usual PA)
The research assistant informs participants that they are
in the usual PA group and that they should continue with
their usual PA throughout the trial. She/he will thank
them for participating and inform them that they will be
contacted later to arrange the 3-month postal assessment
and the 12-month outcome assessment appointment at
the practice, including wearing an accelerometer for 7 days
as part of these. He/she will also make contact at 6 and
9 months (by telephone, text, or email according to pa-
tient preference) to check on safety outcomes and contact
details. On study completion, the control group will be
offered a pedometer, diary and written instructions for a
12-week pedometer-based walking programme either by
post or as part of a single practice nurse consultation
(according to patient preference).
Procedure for the pedometer-alone group
The research assistant informs participants that they are in
the pedometer-alone group and arranges to post out a ped-
ometer, PACE-UP patient handbook and diary with easy to
follow written instructions for a 12-week pedometer-based
walking programme. This is based on the participant’s own
baseline pedometer average daily step-count. The research
assistant will telephone 1 week after sending out the ped-
ometer to check that it has arrived safely and is working
properly and to offer a replacement pedometer in the event
of loss or malfunction during the 12-week intervention.
He/she will also check that participants understand the
12-week pedometer-based walking plan and answer any
questions. Arrangements for follow-up at 3, 6, 9 and
12 months are as for the control group. In addition, at
each follow-up, the research assistant will offer a replace-
ment pedometer or batteries, if required. On study com-
pletion, participants in this group will be offered a single
practice nurse PA consultation.
Procedure for the pedometer-plus-nurse-support group
The research assistant informs participants that they are
in the pedometer-plus-nurse-support group and arranges
a practice nurse appointment for their first PA consult-
ation. Participants can be seen individually or as a couple,
for couples both individual goals and opportunities to in-
crease their PA together will be discussed. Arrangements
for follow-up at 3, 6, 9 and 12 months are as for the
pedometer-alone group.
Harris et al. Trials 2013, 14:418 Page 9 of 18
http://www.trialsjournal.com/content/14/1/418
Procedure for qualitative study
The qualitative researcher will approach the non-
participants and the participants, from both interven-
tion groups, as discussed in qualitative participant
recruitment and seek their informed consent for a
semi-structured telephone interview. All interviews will
be audio-recorded (unless participants do not consent,
when contemporaneous field notes will be taken) and
transcribed verbatim professionally. Thematic analysis
will proceed in parallel with the interviews to enable
refinement of the interview guide and purposive
sampling according to emerging themes. The qualitative
research assistant will also run a focus group with the
practice nurses, when all the interventions are completed,
Table 3 Components of the complex intervention for the PACE-UP trial
Components What was provided Group receipt of
components
Additional detail on components
Pedometer Yamax Digi-Walker (Tokyo, Japan) SW-200
model
Pedometer by post group
(sent by post with instructions).
Yamax Digi-Walker is the criterion pedometer
with best accuracy [72-74]. The CW200 model is
used for baseline target setting, because of
7-day memory of consecutive daily steps, but is
bulky to wear and complicated to use. For the
intervention groups we are using the SW-200
model, which is compact, cheaper and simpler.
It provides direct step-count to participants and
requires daily manual recording and re-setting.
Pedometer plus support group
(given by nurse to patients
with instructions).
Patient
handbook,
walking plan
and diary
Patient handbook to support 12-week walking
programme. Suggested individualised walking
plan (Figure 2). Diary to record weekly PA for
12 weeks (step-count and walks) and whether
walking targets have been met each week.
Pedometer by post group
(sent by post).
Participants’ baseline average daily step-count
(from blinded pedometer assessment) is
recorded in the individual’s handbook and diary.
Participants have been informed that adding in
3,000 steps/day (approximately equivalent to a
30-minute brisk walk) on 5 or more days weekly
to their baseline would help them achieve the
recommended PA guidelines, but that this can
be built up gradually. The handbook provides
advice on the health benefits of at least moderate
intensity PA and states that moderate intensity
PA makes you warm and a bit breathless and
increases your heart rate, but that you should
still be able to talk. The handbook and diary
provide written advice on maintaining activity,
and anticipating and managing setbacks. Table 1
lists the BCTs [58] included in the PACE-UP
patient handbook and diary, respectively.
Pedometer plus support group
(given by nurse to patients).
Practice nurse
PA consultations
Three individually tailored PA consultations
with the practice nurse. Participants can be
seen individually or as a couple.
Pedometer plus support group
only.
Session timings, content and planned BCTs [58]
(Table 2). Most BCTs overlap with those in the
patient handbook and diary to reinforce
consultations. The face-to-face nurse consultation
allows some additional BCTs to be used; e.g.,
communication strategies to overcome resistance
and promote patient-led change using motiv-
ational interviewing techniques and a scale to
check confidence levels and build confidence to
make change. In the first consultation, the nurse
provides the pedometer, patient handbook and
diary. The patient’s baseline blinded pedometer
average daily step-count is reviewed alongside
health and anthropometric data, so that an
individual PA plan, tailored to baseline step-count,
abilities, health and goals and based on increasing
walking and walking speed and other existing PA,
can be produced. The nurse shows participants
how to use the pedometer and how to record
step-counts. Individual tailoring of step-count
increase and how fast to increase this is possible.
Participants are asked to wear a pedometer and
keep daily step-count diary for 4 weeks, until their
next appointment. If goals have been achieved
new goals can be set, if not, then problems and
barriers can be discussed. For couples, both
individual goals and opportunities to increase
their PA together will be discussed.
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this will be audio-recorded and transcribed and subjected
to thematic analysis.
Procedure for the health economics evaluation
The economic evaluation will take the perspective of the
National Health Service personal social services and
participants and first undertake a trial based analysis.
Participant-level resource use data will be collected for
equipment (pedometers), face to face or telephone con-
sultations (length of time and frequency), out of pocket
expenses (e.g., transport costs), use of support services
(number of calls and contacts by post) and for other
health service use (e.g., GP attendances, in-patient days,
out-patient visits, home visits and services from social
services, stays in nursing and residential care). Data will
be collected through primary care records, participant
questionnaire at 3 and 12 months and monitoring by
nurses. Where possible, data collection procedures for
the health economics evaluation will be carried out at
the same time as those for study effectiveness. Costs
that do not vary by use (e.g., development, production
and translation of leaflets) will be estimated separately
Figure 2 Provides a summary of the PACE-UP walking programme.
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and apportioned to patients within the relevant arm of
the trial. Unit costs will be valued using national aver-
ages to increase their generalizability. Long-term costs
and effects expected to occur beyond the trial will be es-
timated using Anokye et al.’s model, which accounts for
the lifetime risk of developing three conditions associ-
ated with PA (coronary heart disease, stroke and type II
diabetes) [75].
Practice nurse training and assessment of fidelity of
practice nurse consultations
Practice nurse training in BCTs and in the use of the
PACE-UP nurse handbook and PACE-UP patient hand-
book and diary will be planned with and conducted by ex-
perienced trainers in BCTs with primary care and practice
nurse training experience (LD and DB) [56]. They will also
provide supervision and monitoring to the nurses over the
course of the trial, including listening to audio-recordings
of a sample of each nurse’s consultations and providing
individual feedback. In addition, the Chief Investigator will
provide training to the nurses on PA and safety aspects of
the trial and the use of pedometers. Nurses will all go on a
walk wearing an accelerometer to try out different walking
speeds and be shown accelerometer feedback to appreciate
the difference between light, moderate and vigorous PA
intensities.
The fidelity and quality of the implementation of the
intervention will be monitored over time and between
different nurses by the following methods: i) analysing
the content of a sample of audiorecorded sessions for
each nurse by the trainers according to an agreed pro-
forma (to include at least one example of each session and
one example of a couple consultation); ii) discussion about
consultations during group supervision/training with all
the nurses; iii) completion of a checklist of areas covered
in each consultation by the nurse; and iv) completion of
a nurse patient alliance questionnaire at the end of each
patient’s intervention by both the nurse and the patient.
The nurse patient alliance questionnaire was drawn up
using a modified version of the Working Alliance Inventory
[76,77] a validated measure of alliance frequently used in
cognitive behavioural therapy based studies, and questions
on patient self-efficacy adapted from the SCI Exercise
Self-Efficacy Scale [78].
Assessment of outcomes after 3 and 12 months in the
intervention and control groups
3-month postal assessment (interim assessment)
As for baseline assessment (including accelerometer as-
sessment) but there is no anthropometric assessment,
and the questionnaire has additional questions about ad-
verse events, injuries and health problems over the last
3 months for all participants and questions on time and
financial costs associated with PA and attending nurse
appointments for the intervention groups as part of the
health economics assessment.
12-month assessment at the patient’s general practice
(primary outcome assessment)
As for baseline assessment (including accelerometer
assessment) but questionnaire has additional questions
about adverse events, including injuries and health
problems and use of pedometer over the last 12 months
(for pedometer use, slightly different questions depending
on group).
Accelerometer data will be downloaded as soon as each
accelerometer is returned. Data entry of questionnaire
data will occur as soon as possible after data collection at
each period. Analysis of outcome data will occur when
data on all participants is complete.
Outcome measures
The primary outcome is change in average daily step-count,
measured over 7 days, between baseline and 12 months
assessed objectively by accelerometry (Actigraph GT3X +
Manufacturing Technology Inc., FL, USA).
Secondary outcomes are:
i) Change in time spent in at least moderate intensity
PA and in time spent sedentary between baseline and
12 months, measured over 7 days by accelerometry.
ii) Change in average daily step-count, time spent in at
least moderate PA and time spent sedentary measured
over 7 days, between baseline and 3 months by
accelerometry.
iii)Cost-effectiveness. Incremental cost of the
intervention to the National Health Service and
incremental cost per change in step-count and per
quality adjusted life year.
Other ancillary outcome measures:
i) Change in self-reported PA assessed by GPPAQ and
IPAQ.
ii) Change in other patient reported outcomes from the
questionnaire (exercise self-efficacy, anxiety,
depression, EQ-5D).
iii)Change in anthropometric measurements; weight,
BMI, waist circumference, body fat, bioimpedance.
iv)Adverse outcomes; data on falls, injuries, major
cardiovascular disease events and deaths will be
collected as part of safety monitoring for the trial,
through participant and nurse reporting,
questionnaires at 3 and 12 months and primary care
records after 12 month follow-up.
v) Health service use – number of and diagnoses for all
primary care consultations during the 12 months of
the trial, as well as any out of hours, A & E, or
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in-patient attendances that lead to new diagnoses
recorded in computerised primary care records,
downloaded at the end of the study, given
participants’ consent.
Qualitative outcomes
There will be a range of outcomes from qualitative in-
terviews and focus groups for non-participants, partici-
pants and practice nurses involved in implementing the
intervention. We will gain an in-depth understanding of
the acceptability and challenges with the interventions
for participants and practice nurses, as well as valuable
insights into the factors influencing why people opt not
to participate in the intervention.
Sample size
A meta-analysis of a heterogeneous group of short-term
intervention studies involving pedometers showed inter-
ventions increased steps count per day by 2,500 with a
SD of 2,700 [23]. However, a smaller increase in steps of
1,000 per day would lead to worthwhile health gains if
this was sustained for 12 months. We also want to be
able to demonstrate whether there are differences in the
effects achieved by a pedometer intervention alone com-
pared with a pedometer intervention with nurse support.
A sample of 217 patients in each of three arms would
allow a difference of 1,000 steps per day to be detected
between any two arms of the trial with a 90% power at
the 1% significance level. This means that we will have
sufficient power to adjust for multiple hypothesis testing.
However, we plan to randomise households. For men
and women the effect of clustering is likely to be small
but needs to be taken into account when stratifying by
age. Assuming an intra-cluster correlation of 0.5 and an
average household size of 1.6 eligible patients we would
need to analyse 282 patients per arm. Allowing for ap-
proximately 15% attrition, we would need to randomise
a total of 993 patients (331 usual PA, 331 pedometer
only and 331 pedometer plus nurse support). Six general
practices (centres) each recruiting approximately 166 pa-
tients will suffice. We will select patients at random to
take part until required numbers have been randomised.
Anticipated recruitment
We anticipate a recruitment rate of 20% amongst those
eligible to participate. This estimate is based on pilot
work using pedometers and accelerometers in an observa-
tional study of older primary care patients, recruitment
rate 43% [42] and other studies of PA interventions (in-
cluding with pedometers) amongst middle-aged and older
adults in primary care, where recruitment has been be-
tween 6% and 35% [25,79-83]. Even if our recruitment rate
were as low as 10%, we would have enough eligible partici-
pants (Figure 1).
Statistical analysis
Analysis and reporting will be in line with CONSORT
guidelines, with primary analyses being on an intention-
to-treat basis. That is, all participants will be included
who have outcome data, regardless of their adherence to
the interventions. Sensitivity analyses including all ran-
domised patients will be carried out using multiple im-
putation to impute PA levels at 12 months for subjects
randomised but with no adequate accelerometry data at
12 months; baseline data are available for all subjects
by definition. All participants will be included in the
primary analysis if they have at least one satisfactory
day of accelerometer recording out of 7 days at 12-
month follow-up. A satisfactory recording comprises at
least 540 minutes (9 hours) of registered time during a
day. Adequacy of the randomisation process to achieve
balanced groups will be checked by comparing partici-
pant characteristics in the three arms (e.g., age, sex,
socio-economic group, baseline PA level, health status,
body mass index, household size). The same variables
will be compared between those who complete follow-up
and those who drop out completely, and those who fail to
provide a complete set of 5 days data for the primary out-
come. Significance tests, either t-test or χ2 tests, will be
used to compare those with complete data and those who
have missing outcomes.
Primary analysis
The primary outcome measure is change in step-count
from baseline to 12-month follow-up. Secondary outcome
measures which we will also examine are counts per mi-
nute, counts per minute of registered time and number of
minutes spent in moderate or vigorous PA. These mea-
sures are likely to be highly correlated with step count and
will be analysed using identical approaches to that for step
count. The primary analysis will use all patients with at
least 1 day of adequate accelerometry data at 12 months
(i.e., complete case analysis). The main outcome will be
the change in average daily step-count measured over
7 days between baseline and 12 months. In practice, we
will regress average daily step-count at 12 months on
average baseline steps per day; this will effectively be
measuring change in number of steps over the 12 months.
Subsidiary analyses
Subsidiary analysis will investigate whether there is any
evidence of interaction, that is whether the treatment ef-
fect varies by the following factors: age (<60 versus ≥60),
gender, socio-economic group, ethnic group, participating
as a couple, disability, health status, BMI and exercise
self-efficacy. Numbers in each group who have suffered
a fracture, falls and injuries, and dropouts will be com-
pared between the groups using logistic regression in
STATA, adjusted for clustering.
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Stopping rules
It would be impossible to carry out interim analyses on
sufficient patients to decide to stop, so there are no formal
statistical stopping rules. If a patient becomes ineligible,
the nurse may discontinue the intervention, but all pa-
tients will be asked to complete follow-up assessments.
Patients can withdraw at any time.
Procedure for accounting for missing data
Only days with at least 540 minutes of registered time
on accelerometer on a given day will be used. Participants
in all groups with less than three days satisfactory wear
time at follow-up will be asked to wear the accelerometer
for an addidional week and the second set of readings
used if greater wear time. Participants will only be ran-
domized if they provide at least five such days of acceler-
ometer data at baseline. We will use a mixed effects
multilevel linear regression model of daily step count, tak-
ing account of day of the week and days since start of
measurement to estimate the baseline average daily steps
for each subject. The main analysis of effect will include
all subjects with at least one satisfactory day of recording
at 12 months. We will estimate average daily steps at
12 months for each subject using an identical approach
to that at baseline; we will then regress estimated PA
level at 12 months on estimated PA level at baseline,
age, sex and practice as well as treatment group, while
including household as a random effect. In a further
sensitivity analysis, we will use multiple imputation to
impute values for those with no accelerometer data at
12 months.
Participant withdrawal
Participants will be free to withdraw from the trial at
any time and without giving a reason. Practice nurses
can advise discontinuation of the PA intervention if the
intervention poses a hazard to the participant. In both
cases, information that has already been collected on
participants may still be used and they will be asked if
they would be prepared to provide any further data on
outcomes at 3 months and 12 months (e.g., questionnaire,
anthropometric measurements and/or PA monitoring).
Withdrawal from the study will not affect the standard of
care received by the practice. If participants withdraw be-
fore they have been randomised they will be replaced,
those withdrawing or being withdrawn after randomisa-
tion will not be replaced.
Adverse event monitoring
Notification and reporting of adverse events
A standard operating procedure for the management of
adverse events will be in place, so that participants or
their relatives, practice staff or researchers can inform
the chief investigator of any event. All adverse events
reported will be assessed for seriousness, expectedness
and causality.
Retrospective data collection on adverse events
i) Questionnaires: Intervention and control groups will
be sent questionnaires at 3 and 12 months that will
ask specifically about falls, injuries and exacerbation
of any pre-existing conditions in the previous 3- and
12-month periods, respectively.
ii) Contact with research assistant: Participants in all
three groups will be contacted at 6 and 9 months
(by telephone, text or email as preferred by
participant) and asked about adverse events since
the last contact.
iii)Computerised primary care records: In order to be
sure that full data on adverse events is collected,
informed consent will be sought to collect data from
participant records at the end of the study. All
consultation data for the 12-month period of the
study for each individual will be downloaded from
practice computerised records, including all new
problems/diagnoses recorded during this period.
This will be anonymised before removal from the
practice and a researcher who is blind to the
intervention or control status of the participants will
analyse this data with a standardised proforma
recording possible adverse events.
Ethical and organizational review
The trial has been reviewed and given a favourable opinion
by the London Research Ethics Committee (Hampstead)
(12/LO/0219). National Health Service Research and
Development approval was given initially by Primary
Care Trusts and then by Clinical Commissioning
Groups in South West London to cover all the practice
sites.
Discussion
The PACE-UP trial is a primary care based PA inter-
vention for inactive 45–75 year olds which seeks to
discover if provision of a pedometer by post as part of
a 12-week walking programme can increase PA levels
at 12 months compared with usual care and whether
additional practice nurse PA consultations can increase
any effects. It is a pragmatic trial being conducted
across several general practices with patients’ own
practice nurses, rather than trained researchers or
therapists delivering the intervention. The findings will
therefore be of direct relevance to UK primary care
and other developed countries with similar healthcare
provision.
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We have taken the following measures in the trial to
minimise or avoid bias:
i) Randomisation: The Kings College Clinical Trials
Unit internet randomisation service will be used to
ensure allocation concealment. Randomisation will
be at household level to avoid couple contamination
(see below).
ii) Contamination: Contamination could occur between
partners in the same household. This will be
minimised by ensuring that if both are recruited
they are allocated to the same group. Contamination
could also occur in the control ‘usual PA’ group if
they seek to increase their PA. Participants will be
discouraged from buying a pedometer by ensuring
that they know that they will receive one, along with
instructions on its use and the offer of a PA
consultation with their practice nurse and feedback
on their individual activity levels at the end of the
trial. The 3-month and 12-month assessments will
capture information on PA in the usual PA group,
including a question at 12 months about whether
they have used a pedometer at all in the previous
year.
iii)Blinding and assessment of outcomes: Participants
cannot be blinded to their intervention or control
status. The research assistants assessing outcomes
will not be blinded to the participants’ intervention
status for pragmatic reasons; the study is funded to
support only two research assistants to carry out
recruitment and follow-up simultaneously at their
allocated practices. Appointments for the 3-month
and 12-month outcome assessments will be booked
in advance according to a protocol, taking into
account holidays. However, primary and secondary
outcome measures are objectively measured by
accelerometry and do not rely on assessor
interpretation. Physical measurements will also be
assessed objectively (e.g., body weight and body fat
measurements using scales with print-out results).
Patient reported outcomes will be assessed by
validated self-report instruments, minimising
researcher bias. The statistician analysing the data
will be blind to the treatment allocation of the
participants.
The particular challenges that we anticipate in this study
are as follows:
i) Low levels of recruitment and possible selection
bias, with those who are more physically active
being more likely to want to take part. We have a
screening question to filter out those who already
report recommended PA levels, this should
minimize the number who are too active taking part.
We are addressing potential low levels of
recruitment by recruiting from practices with
enough people in the target age range for us to
achieve our sample size even if recruitment were as
low as 10% of those eligible. In order to estimate
response bias we aim to assess self-reported PA and
health on those who are not recruited to the trial,
but who are willing to fill out a short questionnaire.
ii) Variation in the PA interventions delivered across
practices and over time. We have several quality
assurance mechanisms in place (including protocols
for research assistants who are delivering the postal
intervention, and protocols, audio-recording of
consultations, group supervision, nurse checklists
and patient nurse alliance scales for the nurses
delivering the PA consultations) to help us to avoid
and monitor these aspects of fidelity.
iii)Losses to follow-up, particularly the control group.
We hope to reduce this in the following ways:
personal contact with the same research assistant;
the offer of a £10 gift voucher when accelerometers
are returned; offering controls individual feedback
on their activity levels after they complete the trial
from their baseline, 3-month and 12-month
assessments; and offering a pedometer and 12-week
individualized walking programme, either by post or
in a single nurse PA consultation, after trial
completion.
The findings of this trial will contribute importantly to
the development of strategies to address a key global
public health challenge, low PA among adults and older
adults. Specifically in the UK, an understanding of the
role of pedometer-based programmes and nurse support
will help guide national policy on promoting PA in pri-
mary care. If effective and cost-effective, our interventions
could be incorporated into the National Health Service
Health Check Programme, which targets patients aged
40–74 years. More widely, our findings will be able to
guide international policy and recommendations for
increasing PA.
Trial status
In recruitment phase (recruitment started October 2013
and anticipated to finish November 2013).
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